Anbio Biotechnology Class A Ordinary Shares
NNNN · NASDAQ
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,325 | $3,887 | $793 | $1,643 |
| Dep. & Amort. | $0 | $0 | $4 | $9 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $3,139 | -$3,091 | -$1,971 | $668 |
| Other Non-Cash | -$210 | -$149 | -$157 | -$18 |
| Operating Cash Flow | $1,604 | $648 | -$1,332 | $2,303 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$11,364 | -$27,028 | -$20,058 | $0 |
| Inv. Sales/Matur. | $11,580 | $27,178 | $20,219 | $1,711 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $216 | $149 | $161 | $1,711 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | -$249 | -$124 | $230 | -$276 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | -$249 | -$124 | $230 | -$276 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $0 | $0 | $0 | $0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $11,050 | $10,702 | $0 | $0 |
| End Cash | $12,178 | $11,050 | $10,702 | $0 |
| Free Cash Flow | $1,604 | $648 | -$1,332 | $2,303 |